Unither Pharmaceuticals
FranceEntry
2023
Hold
3yr
Status
Active
Who owns Unither Pharmaceuticals?
Unither Pharmaceuticals is currently owned by IK Partners through IK Partnership Fund II (2022 vintage), since 2023. Across its history, Unither Pharmaceuticals has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · 3 sources · updated 2026-04-21
Most recent investor
IK PartnersIK Partnership Fund II · 2022 · Growth
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Keensight Capital, Ardian and IK Partners since 2017.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2017 · present
Keensight CapitalActive
2017 · present(9yr) · Keensight Nova V · 2019 · Buyout
ArdianActive
2017 · present(9yr) · Ardian Other Investments
IK PartnersActive
2023 · present(3yr) · IK Partnership Fund II · 2022 · Growth
More from IK Partnership Fund II
Other portfolio companies in the same fund.
UK
Germany
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Track Unither Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Unither Pharmaceuticals?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Unither Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
6 verified KPIs (Revenue, EBITDA, growth)
Hand-checked deal notes on this investment
3 source links for every datapoint
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue